<?xml version="1.0" encoding="utf-8" ?>

<XML>
  <JOURNAL>   
    <YEAR>2016</YEAR>
    <VOL>8</VOL>
    <NO>3</NO>
    <MOSALSAL>30</MOSALSAL>
    <PAGE_NO>47</PAGE_NO>  
    <ARTICLES>

<ARTICLE>
    <TitleE>Future directions for translation of tissue engineering products into clinic</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;At present, Iran has been known one of the up-warding countries in the world in regenerative medicine using stem cells therapy. In fact, the outcomes of some clinical trials on stem cell therapy of myocardial infarction, vitiligo, decompensated cirrhosis, and osteoarthritis narrate the feasibility of stem cell-based therapy for treatment of human diseases &lt;sup&gt;1,2&lt;/sup&gt;. However, in a similar manner with global configuration, the commercialization and translation of tissue engineering products into clinical phase has been restricted. It might be due to weak collaboration of different specialties for technology transfer of the multidisciplinary projects of tissue engineering field into clinical phase. Basic tissue engineers mostly prefer elegant studies, whereas physicians have tendency to solve medical problems with products indicating efficiency, easy to use, and cost benefit. Actually, a surgeon encountered with a dilemma between a partially effective tissue-engineered product that is both expensive and difficult to apply and a more traditional approach may choose the latter option. Therefore, a coherent teamwork between basic sciences and medicine as well as acquisition of competent knowledge about target tissue is necessary to conduct tissue engineering in the clinic. Moreover, it should be considered that in developing countries including Iran the high cost of high-tech biomedical research necessitates government investment &lt;sup&gt;3&lt;/sup&gt;. Currently, the policy makers have established some action plans to support of science-based companies financially. This is a suitable opportunity to ligature basic research and market for commercialization of tissue engineering products. However, because private investors beyond academic laboratories should provide financing of tissue engineering products, incentive of private companies for investment should not be neglected. It is notable that tissue-engineered products will fulfill small market size unless they could indicate much superior results than competitive alternatives.&lt;br /&gt;
It is noticeable that tissue engineers should determine the requirements of community and develop strategies to penetrate the products into clinic. Indeed, the communication between scientists and policy makers should be increased to better definition of national research priorities. On the other hand, considering local necessities and natural resources should be rather than subjective experts&amp;rsquo; notions or international superiorities. Finally, ethical and legal regulations should be actually defined that indubitably make great profits to the society.&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>103</FPAGE>
            <TPAGE>103</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Somaieh</Name>
<MidName></MidName>
<Family>Kazemnejad</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Editorial</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>240.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Mobini S, Khanmohammadi M, Heidari-Vala H, Samadikuchaksaraei A, Moshiri A, Kazemnejad S. Tissue Engineering and Regenerative Medicine in Iran: Current State of Research and Future Outlook. Mol Biotechnol 2015;57(7):589-605.##Gheisari Y, Baharvand H, Nayernia K, Vasei M. Stem cell and tissue engineering research in the Islamic Republic of Iran. Stem Cell Rev 2012;8(3):629-639.##Samadikuchaksaraei A, Mousavizadeh K. High-tech biomedical research: lessons from Iran&#39;s experience. Biomed Eng Online 2008;7:17.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Development of a Single Stranded DNA Aptamer as a Molecular Probe for LNCap Cells Using Cell-SELEX</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Nowadays, highly specific aptamers generated by cell SELEX technology (systematic evolution of ligands by exponential enrichment) are being applied for early detection of cancer cells. Prostate Specific Membrane Antigen (PSMA), over expressed in prostate cancer, is a highly specific marker and therefore can be used for diagnosis of the prostate cancer cells. The aim of the present study was to select single-stranded DNA aptamers against LNCap cells highly expressing PSMA, using cell&amp;ndash;SELEX method which can be used as a diagnostic tool for the detection of prostate cancer cells.&lt;br /&gt;
Methods: After 10 rounds of cell-SELEX, DNA aptamers were isolated against PSMA using LNCaP cells as a target and PC-3 cell lines for counter SELEX. Five DNA aptamers with more than 70% affinity were selected up on flow cytometry analysis of positive clones.&lt;br /&gt;
Results: Dissociation constants of two selected sequences (A12-B1) were estimated in the range of 33.78&amp;plusmn;3.77 and 57.49&amp;plusmn;2.214 &lt;em&gt;pmol&lt;/em&gt;, respectively. Conserved secondary structures of A12 and B1 sequences suggest the necessity of these structures for binding with high affinity to native PSMA. Comparison of the secondary structures of our isolated aptamers and aptamer A10 obtained by protein SELEX showed similar stem-loop structures which could be responsible for the recognition of PSMA on LNCap cell surface.&lt;br /&gt;
Conclusion: Our results indicated that selected aptamers may turn out to be ideal candidates for the development of a detection tool and also can be used in targeted drug delivery for future smart drugs.&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>104</FPAGE>
            <TPAGE>111</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Faezeh</Name>
<MidName></MidName>
<Family>Almasi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biotechnology, College of Science, Tehran University</Organization>
</Organizations>
<Universities>
<University>Department of Biotechnology, College of Science, Tehran University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Seyed Latif</Name>
<MidName></MidName>
<Family>Mousavi Gargari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, Shahed University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, Shahed University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatemeh</Name>
<MidName></MidName>
<Family>Bitaraf</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, Shahed University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, Shahed University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Samaneh</Name>
<MidName></MidName>
<Family>Rasoulinejad</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, Shahed University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, Shahed University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Cell-SELEX</KeyText></KEYWORD><KEYWORD><KeyText>DNA aptamer</KeyText></KEYWORD><KEYWORD><KeyText>Exonucleases</KeyText></KEYWORD><KEYWORD><KeyText>Prostate specific membrane antigen </KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>242.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63(1):11-30.##Lepor A, Catalona WJ, Loeb S. The prostate health index: its utility in prostate cancer detection. Urol Clin North Am 2016;43(1):1-6.##Bacich DJ, Pinto JT, Tong WP, Heston WD. Cloning, expression, genomic localization and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase. Mamm Genome 2001;12(2):117-123.##Beckett ML, Cazares LH, Vlahou A, Schellhammer PF, Wright GL Jr. Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer. Clin Cancer Res 1999;5(12):4034-4040.##Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol 2005;288(5):C975-981.##Cibiel A, Pestourie C, Ducong&#233; F. In vivo uses of aptamers selected against cell surface biomarkers for therapy and molecular imaging. Biochimie 2012;94(7):1595-1606.##Nery AA, Wrenger C, Ulrich H. Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agents. J Sep Sci 2009;32(10):1523-1530.##Bitaraf FS, Rasooli I, Mousavi Gargari SL. DNA aptamers for the detection of Haemophilus influenzae type b by cell SELEX. Eur J Clin Microbiol Infect Dis 2016;35(3):503-510.##Ohuchi S. Cell-SELEX Technology. Biores Open Access 2012;1(6):265-272.##Lupold SE, Hicke BJ, Lin Y, Coffey DS. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 2002;62(14):4029-4033.##Dassie JP, Liu XY, Thomas GS, Whitaker RM, Thiel KW, Stockdale KR, et al. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol 2009;27(9):839-849.##Ni X, Zhang Y, Ribas J, Chowdhury WH, Castanares M, Zhang Z, et al. Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. J Clin Invest 2011;121(6):2383-2390.##Chu TC, Marks JW 3rd, Lavery LA, Faulkner S, Rosenblum MG, Ellington AD, et al. Aptamer: toxin conjugates that specifically target prostate tumor cells. Cancer Res 2006;66(12):5989-5992.##Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci USA 2008;105(45):17356-17361.##Kasten BB, Liu T, Nedrow-Byers JR, Benny PD, Berkman CE. Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles. Bioorg Med Chem Lett 2013;23(2):565-568.##Xu W, Siddiqui IA, Nihal M, Pilla S, Rosenthal K, Mukhtar H, et al. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials 2013;34(21):5244-5253.##Wang AZ, Bagalkot V, Vasilliou CC, Gu F, Alexis F, Zhang L, et al. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem 2008;3(9):1311-1315.##Ben Jemaa A, Bouraoui Y, Sallami S, Banasr A, Ben Rais N, Ouertani L, et al. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies. J Exp Clin Cancer Res 2010;29:171.##Tewari A, ed. Prostate cancer: A comprehensive perspective. 1st ed. London: Springer-Verlag; 2013. 1110 p.##Actis P, Rogers A, Nivala J, Vilozny B, Seger RA, Jejelowo O, et al. Reversible thrombin detection by aptamer functionalized STING sensors. Biosens Bioelectron 2011;26(11):4503-4507.##Meyer C, Hahn U, Rentmeister A. Cell-specific aptamers as emerging therapeutics. J Nucleic Acids 2011;2011:904750.##Zare H, Rajabibazl M, Rasooli I, Ebrahimizadeh W, Bakherad H, Ardakani LS, et al. Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells. Int J Biol Markers 2014;29(2):e169-179.##Colombatti M, Grasso S, Porzia A, Fracasso G, Scupoli MT, Cingarlini S, et al. The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. PLoS One 2009;4(2):e4608.##Min K, Song KM, Cho M, Chun YS, Shim YB, Ku JK, et al. Simultaneous electrochemical detection of both PSMA (+) and PSMA (-) prostate cancer cells using an RNA/peptide dual-aptamer probe. Chem Commun (Camb) 2010;46(30):5566-5568.##Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 1999;59(13):3192-3198.##Zamay GS, Kolovskaya OS, Zamay TN, Glazyrin YE, Krat AV, Zubkova O, et al. Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood. Mol Ther 2015;23(9):1486-1496.##Dua P, Kim S, Lee DK. Nucleic acid aptamers targeting cell-surface proteins. Methods 2011;54(2):215-225.##Cerchia L, de Franciscis V. Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol 2010;28(10):517-525.##Dassie JP, Hernandez LI, Thomas GS, Long ME, Rockey WM, Howell CA, et al. Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen. Mol Ther 2014;22(11):1910-1922.##Liu Y, Kuan CT, Mi J, Zhang X, Clary BM, Bigner DD, et al. Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis. Biol Chem 2009;390(2):137-144.##Cerchia L, Ducong&#233; F, Pestourie C, Boulay J, Aissouni Y, Gombert K, et al. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol 2005;3(4):e123.##Avci-Adali M, Paul A, Wilhelm N, Ziemer G, Wendel HP. Upgrading SELEX technology by using lambda exonuclease digestion for single-stranded DNA generation. Molecules 2009;15(1):1-11.##Citartan M, Tang TH, Tan SC, Gopinath SCB.  Conditions optimized for the preparation of single-stranded DNA (ssDNA) employing lambda exonuclease digestion in generating DNA aptamer. World J Microbiol Biotechnol 2011;27(5):1167-1173.##Marimuthu C, Tang TH, Tominaga J, Tan SC, Gopinath SC. Single-stranded DNA (ssDNA) production in DNA aptamer generation. Analyst 2012;137(6):1307-1315.##Dapprich J. Single-molecule DNA digestion by lambda-exonuclease. Cytometry 1999;36(3):163-168.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>The Cytotoxicity of Dacarbazine Potentiated by Sea Cucumber Saponin in Resistant B16F10 Melanoma Cells through Apoptosis Induction</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Malignant melanoma is a highly aggressive malignant melanocytic neoplasm which resists against the most conventional therapies. Sea cucumber as one of marine organisms contains bioactive compounds such as polysaccharide, terpenoid and other metabolites which have anti-cancer, anti-tumor, anti-inflammatory and antioxidant properties. The present study was designed to investigate the anticancer potential of saponin extracted from sea cucumber &lt;em&gt;Holothuria leucospilata&lt;/em&gt; alone and in combination with dacarbazine on B16F10 melanoma cell line.&lt;br /&gt;
Methods: The B16F10 cell line was treated with different concentrations of saponin (0, 4, 8, 12, 16, 20 &lt;em&gt;&amp;micro;g/ml&lt;/em&gt;), dacarbazine (0, 1200, 1400, 1600, 1800, 2000&lt;em&gt; &amp;micro;g/ml&lt;/em&gt;) and co-administration of saponin-dacarbazine (1200 da+8 sp, 1200 da+4 sp) for 24 and 48 &lt;em&gt;hr&lt;/em&gt; and the cytotoxic effect was examined by MTT, DAPI, acridine orange/propodium iodide, flow cytometry and caspase colorimetric assay.&lt;br /&gt;
Results: The results exhibited that sea cucumber saponin, dacarbazine, and co-administration of saponin-dacarbazine inhibited the proliferation of melanoma cells in a dose and time dependent manner with IC&lt;sub&gt;50&lt;/sub&gt; values of 10, 1400 and 4+1200 &lt;em&gt;&amp;micro;g/ml&lt;/em&gt;, respectively. Morphological observation of DAPI and acridine orange/propodium iodide staining documented typical characteristics of apoptotic cell death. Flow cytometry assay indicated accumulation of IC&lt;sub&gt;50&lt;/sub&gt; treated cells in sub-G1 peak. Additionally, saponin extracted induced intrinsic apoptosis &lt;em&gt;via&lt;/em&gt; up-regulation of caspase-3 and caspase-9.&lt;br /&gt;
Conclusion: These results revealed that the saponin extracted from sea cucumber as a natural anti-cancer compound may be a new treatment modality for metastatic melanoma and the application of sea cucumber saponin in combination with dacarbazine demonstrated the strongest anti-cancer activity as compared with the drug alone.&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>112</FPAGE>
            <TPAGE>119</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Javad</Name>
<MidName></MidName>
<Family>Baharara</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, Research Center for Applied Biology, Mashhad Branch, Islamic Azad University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, Research Center for Applied Biology, Mashhad Branch, Islamic Azad University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Elaheh</Name>
<MidName></MidName>
<Family>Amini</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University</Organization>
</Organizations>
<Universities>
<University>Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Najme</Name>
<MidName></MidName>
<Family>Nikdel</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Research Center for Applied Biology, Mashhad Branch, Islamic Azad University</Organization>
</Organizations>
<Universities>
<University>Research Center for Applied Biology, Mashhad Branch, Islamic Azad University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Farzaneh</Name>
<MidName></MidName>
<Family>Salek-Abdollahi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Research Center for Applied Biology, Mashhad Branch, Islamic Azad University</Organization>
</Organizations>
<Universities>
<University>Research Center for Applied Biology, Mashhad Branch, Islamic Azad University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Apoptosis</KeyText></KEYWORD><KEYWORD><KeyText>Dacarbazine</KeyText></KEYWORD><KEYWORD><KeyText>Melanoma</KeyText></KEYWORD><KEYWORD><KeyText>Saponins</KeyText></KEYWORD><KEYWORD><KeyText>Sea cucumbers</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>243.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Khoobchandani M, Ganesh N, Gabbanini S, Valgimigli L, Srivastava MM. Phytochemical potential of Eruca sativa for inhibition of melanoma tumor growth. Fitoterapia 2011;82(4):647-653.##Salma Y, Lafont E, Therville N, Carpentier S, Bonnaf&#233; MJ, Levade T, et al. The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism. Biochem Pharmacol 2009;78(5):477-485.##D&#39;Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. UV radiation and the skin. Int J Mol Sci 2013;14(6):12222-12248.##Chinembiri TN, du Plessis LH, Gerber M, Hamman JH, du Plessis J. Review of natural compounds for potential skin cancer treatment. Molecules 2014;19(8):11679-11721.##Zigler M, Villares GJ, Lev DC, Melnikova VO, Bar-Eli M. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. Am J Clin Dermatol 2008;9(5):307-311.##Grossman D, Altieri DC. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev 2001;20(1-2):3-11.##Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N. Apoptosis and molecular targeting therapy in cancer. Biomed Res Int 2014;2014:150845.##Kumar A, Patil D, Rajamohanan PR, Ahmad A. Isolation, purification and characterization of vinblastine and vincristine from endophytic fungus Fusarium oxysporum isolated from Catharanthus roseus. PLoS One 2013;8(9):e71805.##Orouji A, Goerdt S, Utikal J. Systemic therapy of non-resectable metastatic melanoma. Cancers (Basel) 2010;2(2):955-969.##Lev DC, Onn A, Melinkova VO, Miller C, Stone V, Ruiz M, et al. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. J Clin Oncol 2004;22(11):2092-2100.##Kuppusamy P, Yusoff MM, Maniam GP, Govindan N. A case study-regulation and functional mechanisms of cancer cells and control its activity using plants and their derivatives. J Pharm Res 2013;6(8):884-892.##Li YX, Himaya SW, Kim SK. Triterpenoids of marine origin as anti-cancer agents. Molecules 2013;18(7):7886-7909.##Bahrami Y, Zhang W, Franco C. Discovery of novel saponins from the viscera of the sea cucumber Holothuria lessoni. Mar Drugs 2014;12(5):2633-2667.##Esmat AY, Said MM, Soliman AA, El-Masry KS, Badiea EA. Bioactive compounds, antioxidant potential, and hepatoprotective activity of sea cucumber (Holothuria atra) against thioacetamide intoxication in rats. Nutrition 2013;29(1):258-267.##Wijesinghe WA, Jeon YJ, Ramasamy P, Wahid ME, Vairappan CS. Anticancer activity and mediation of apoptosis in human HL-60 leukaemia cells by edible sea cucumber (Holothuria edulis) extract. Food Chem 2013;139(1-4):326-331.##Janakiram NB, Mohammed A, Rao CV. Sea cucumbers metabolites as potent anti-cancer agents. Mar Drugs 2015;13(5):2909-2923.##He NW, Zhao Y, Guo L, Shang J, Yang XB. Antioxidant, antiproliferative, and pro-apoptotic activities of a saponin extract derived from the roots of Panax notoginseng (Burk.) F.H. Chen. J Med Food 2012;15(4):350-359.##Soltani M, Parivar K, Baharara J, Kerachian MA, Asili J. Putative mechanism for apoptosis-inducing properties of crude saponin isolated from sea cucumber (Holothuria leucospilota) as an antioxidant compound. Iran J Basic Med Sci 2015;18(2):180-187.##Hu XQ, Wang YM, Wang JF, Xue Y, Li ZJ, Nagao K, et al. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling. Lipids Health Dis 2010;9:25.##Lewandowska U, Gorlach S, Owczarek K, Hrabec E, Szewczyk K. Synergistic interactions between anticancer chemotherapeutics and phenolic compounds and anticancer synergy between polyphenols. Postepy Hig Med Dosw (Online) 2014;68:528-540.##Swift LH, Golsteyn RM. Genotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells. Int J Mol Sci 2014;15(3):3403-3431.##Bojo ZP, Dea&#241;o CD, Jacinto SD, Concepcion GP. Synergistic in vitro cytotoxicity of adociaquinone B and heptyl prodigiosin against MCF-7 breast cancer cell line. Philipp Sci Lett 2010;3(2):48-58.##Hammerov&#225; J, Uldrijan S, T&#225;borsk&#225; E, Slaninov&#225; I. Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status. J Dermatol Sci 2011;62(1):22-35.##Oktem G, Uysal A, Oral O, Sezer ED, Olukman M, Erol A, et al. Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis. Exp Toxicol Pathol 2012;64(5):471-479.##Tabolacci C, Lentini A, Mattioli P, Provenzano B, Oliverio S, Carlomosti F, et al. Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells. Life Sci 2010;87(9-10):316-324.##Zhang F, Zhang Z, Liu Z. Effects of Huaier aqueous extract on proliferation and apoptosis in the melanoma cell line A875. Acta Histochem 2013;115(7):705-711.##Fujiki H, Suganuma M. Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention. Cancer Lett 2012;324(2):119-125.##Li M, Miao ZH, Chen Z, Chen Q, Gui M, Lin LP, et al. Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase2alpha by unique interference with its DNA binding and catalytic cycle. Ann Oncol 2010;21(3):597-607.##Salma Y, Lafont E, Therville N, Carpentier S, Bonnaf&#233; MJ, Levade T, et al. The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism. Biochem Pharmacol 2009;78(5):477-485.##Amini E, Nabiuni M, Baharara J, Parivar K, Asili J. Hemolytic and cytotoxic effects of saponin like compounds isolated from Persian Gulf brittle star (Ophiocoma erinaceus). J Coast Life Med 2014;2(10):762-768.##Baharara J, Amini E, Nikdel N, Afzali M. The pro apoptotic effect of brittle star dichloromethane extract on B16F10 melanoma cell line. J Paramed Sci 2015;6(3):72-78.##Li M, Miao ZH, Chen Z, Chen Q, Gui M, Lin LP, et al. Echinoside A, a new marine-derived anticancer saponin,  targets topoisomerase2alpha by unique interference with its DNA binding and catalytic cycle. Ann Oncol 2010;21(3):597-607.##Soltani M, Parivar K, Baharara J, Kerachian MA, Asili J. Hemolytic and cytotoxic properties of saponin purified from Holothuria leucospilota sea cucumber. Rep Biochem Mol Biol 2014;3(1):43-50.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer’s Disease</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Sporadic Alzheimer&amp;rsquo;s Disease (SAD) is caused by genetic risk factors, aging and oxidative stresses. The herbal extract of &lt;em&gt;Rosa canina (R. canina)&lt;/em&gt;, &lt;em&gt;Tanacetum vulgare (T. vulgare)&lt;/em&gt; and &lt;em&gt;Urtica dioica (U. dioica)&lt;/em&gt; has a beneficial role in aging, as an anti-inflammatory and anti-oxidative agent. In this study, the neuroprotective effects of this herbal extract in the rat model of SAD was investigated.&lt;br /&gt;
Methods: The rats were divided into control, sham, model, herbal extract -treated and ethanol-treated groups. Drug interventions were started on the 21&lt;sup&gt;st&lt;/sup&gt; day after modeling and each treatment group was given the drugs by intraperitoneal (I.P.) route for 21 days. The expression levels of the five important genes for pathogenesis of SAD including &lt;em&gt;Syp, Psen1, Mapk3, Map2&lt;/em&gt; and &lt;em&gt;Tnf-&amp;alpha;&lt;/em&gt; were measured by qPCR between the hippocampi of SAD model which were treated by this herbal extract and control groups. The Morris Water Maze was adapted to test spatial learning and memory ability of the rats.&lt;br /&gt;
Results: Treatment of the rat model of SAD with herbal extract induced a significant change in expression of &lt;em&gt;Syp&lt;/em&gt; (p=0.001) and &lt;em&gt;Psen1&lt;/em&gt; (p=0.029). In Morris Water Maze, significant changes in spatial learning seen in the rat model group were improved in herbal-treated group.&lt;br /&gt;
Conclusion: This herbal extract could have anti-dementia properties and improve spatial learning and memory in SAD rat model.&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>120</FPAGE>
            <TPAGE>125</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Parvaneh</Name>
<MidName></MidName>
<Family>Daneshmand</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Genetic Research Center, University of Social Welfare and Rehabilitation Sciences</Organization>
</Organizations>
<Universities>
<University>Genetic Research Center, University of Social Welfare and Rehabilitation Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Kioomars</Name>
<MidName></MidName>
<Family>Saliminejad</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Marzieh</Name>
<MidName></MidName>
<Family>Dehghan Shasaltaneh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Laboratory of Neuro-organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran</Organization>
</Organizations>
<Universities>
<University>Laboratory of Neuro-organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Koorosh</Name>
<MidName></MidName>
<Family>Kamali</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Gholam Hossein</Name>
<MidName></MidName>
<Family>Riazi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Laboratory of Neuro-organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran</Organization>
</Organizations>
<Universities>
<University>Laboratory of Neuro-organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Reza</Name>
<MidName></MidName>
<Family>Nazari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Laboratory of Neuro-organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran</Organization>
</Organizations>
<Universities>
<University>Laboratory of Neuro-organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Pedram</Name>
<MidName></MidName>
<Family>Azimzadeh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Shahid Beheshti University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Shahid Beheshti University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Hamid Reza</Name>
<MidName></MidName>
<Family>Khorram Khorshid</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Genetic Research Center, University of Social Welfare and Rehabilitation Sciences</Organization>
</Organizations>
<Universities>
<University>Genetic Research Center, University of Social Welfare and Rehabilitation Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Alzheimer disease</KeyText></KEYWORD><KEYWORD><KeyText>Gene expression</KeyText></KEYWORD><KEYWORD><KeyText>Herbal extract</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>244.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Diwu YC, Tian JZ, Shi J. Effects of Chinese herbal medicine Yinsiwei compound on spatial learning and memory ability and the ultrastructure of hippocampal neurons in a rat model of sporadic Alzheimer disease. Zhong Xi Yi Jie He Xue Bao 2011;9(2):209-215.##Moceri VM, Kukull WA, Emanual I, van Belle G, Starr JR, Schellenberg GD, et al. Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer&#39;s disease. Epidemiology 2001;12(4):383-389.##Iqbal K, Grundke-Iqbal I. Metabolic/signal transduction hypothesis of Alzheimer’s disease and other tauopathies. Acta Neuropathol 2005;109(1):25-31.##Tuppo EE, Arias HR. The role of inflammation in Alzheimer&#39;s disease. Int J Biochem Cell Biol 2005;37(2):289-305.##Yin Y, Liu Y, Huang L, Huang S, Zhuang J, Chen X, et al. Anti-apoptosis effect of astragaloside Iv on Alzheimer&#39;s disease rat model via enhancing the expression of Bcl-2 and Bcl-Xl. Scand J Lab Anim Sci 2010;37(2):75-82.##Chen Y, Tian Z, Liang Z, Sun S, Dai CL, Lee MH, et al. Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer&#39;s disease. PLoS One 2012;7(12):e51432.##Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol 1999;58(3):275-287.##Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 2002;70(3):462-473.##Rutten BP, Van der Kolk NM, Schafer S, van Zandvoort MA, Bayer TA, Steinbusch HW, et al. Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice. Am J Pathol 2005;167(1):161-173.##Ishibashi K, Tomiyama T, Nishitsuji K, Hara M, Mori H. Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer&#39;s disease brain. J Neurosci Res 2006;84(3):632-636.##Theuns J, Van Broeckhoven C. Transcriptional regulation of Alzheimer&#39;s disease genes: implications for susceptibility. Hum Mol Genet 2000;9(16):2383-2394.##Chumakov I, Nabirotchkin S, Cholet N, Milet A, Boucard A, Toulorge D, et al. Combining two repurposed drugs as a promising approach for Alzheimer&#39;s disease therapy. Sci Rep 2015;5:7608.##Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 2009;118(1):53-69.##Li R, Yang L, Lindholm K, Konishi Y, Yue X, Hampel H, et al. Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death. J Neurosci 2004;24(7):1760-1771.##Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer&#39;s disease. Neuron 2004;44(1):181-193.##Mohraz M, Khairandish P, Kazerooni PA, Davarpanah MA, Shahhosseiny MH, Mahdavian B, et al. A clinical trial on the efficacy of IMOD in AIDS patients. Daru 2009;17(4):277-284.##Mahmoodpoor A, Eslami K, Mojtahedzadeh M, Najafi A, Ahmadi A, Dehnadi-Moghadam A, et al. Examination of Setarud (IMOD™) in the management of patients with severe sepsis. Daru 2010;18(1):23-28.##Mohseni-Salehi-Monfared SS, Habibollahzadeh E, Sadeghi H, Baeeri M, Abdollahi M. Efficacy of Setarud (IMOD™), a novel electromagnetically-treated multi-herbal compound, in mouse immunogenic type-1 diabetes. Arch Med Sci 2010;6(5):663-669.##Mohammadirad A, Khorram-Khorshid HR, Gharibdoost F, Abdollahi M. Setarud (IMODTM) as a Multiherbal Drug with Promising Benefits in Animal and Human Studies: A comprehensive review of biochemical and cellular evidences. Asian J Anim Vet Adv 2011;6(12):1185-1192.##Ghanbari S, Yonessi M, Mohammadirad A, Gholami M, Baeeri M, Khorram-Khorshid HR, et al. Effects of IMOD™ and Angipars™ on mouse D-galactose-induced model of aging. Daru 2012;20(1):68.##Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SS. Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer&#39;s disease in rats. J Mol Neurosci 2012;46(1):223-235.##Zhou S, Yu G, Chi L, Zhu J, Zhang W, Zhang Y, et al. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats. Neurotoxicology 2013;38:136-145.##Care IoLARCo, Animals UoL, Resources NIoHDoR. Guide for the care and use of laboratory animals: National Academies 1985.##National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC): National Academies Press (US); 2011. 246 p.##Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Australia: Academic press; 2004. 456 p.##Silver N, Cotroneo E, Proctor G, Osailan S, Paterson KL, Carpenter GH. Selection of housekeeping genes for gene expression studies in the adult rat submandibular gland under normal, inflamed, atrophic and regenerative states. BMC Mol Biol 2008;9:64.##Moura AC, Lazzari VM, Agnes G, Almeida S, Giovenardi M, Veiga AB. Transcriptional expression study in the central nervous system of rats: what gene should be used as internal control? Einstein (Sao Paulo) 2014;12(3):336-341. English, Portuguese.##Chen XF, Zhang YW, Xu H, Bu G. Transcriptional regulation and its misregulation in Alzheimer&#39;s disease. Mol Brain 2013;6:44.##Selkoe DJ. Alzheimer&#39;s disease is a synaptic failure. Science 2002;298(5594):789-791.##Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004;62(6):925-931.##Saganich MJ, Schroeder BE, Galvan V, Bredesen DE, Koo EH, Heinemann SF. Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J Neurosci 2006;26(52):13428-13436.##Liu L, Orozco IJ, Planel E, Wen Y, Bretteville A, Krishnamurthy P, et al. A transgenic rat that develops Alzheimer&#39;s disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis 2008;31(1):46-57.##Panahi N, Mahmoudian M, Mortazavi P, Hashjin GS. Effects of berberine on β-secretase activity in a rabbit model of Alzheimer&#39;s disease. Arch Med Sci 2013;9(1):146-150.##Sharma V, Deshmukh R. Tumor necrosis factor and alzheimer’s disease: A cause and consequence relationship. Klinik Psikofarmakol B&#252;lteni 2012;22(1):86-97.##Medeiros R, Prediger RD, Passos GF, Pandolfo P, Duarte FS, Franco JL, et al. Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer&#39;s disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci 2007;27(20):5394-5404.##Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer&#39;s disease. J Neurochem 2006;96(1):1-13.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Inhibitory Effects of Some Carbohydrates on Nano-Globular Aggregation of both Normal and Glycated Albumin</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Protein aggregation is one of the important, common and troubling problems in biotechnology, pharmaceutical industries and amyloid-related disorders.&lt;br /&gt;
Methods: In the present study, the inhibitory effects of some carbohydrates (alginate, &amp;beta;-cyclodextrin and trehalose) on the formation of nano-globular aggregates from normal (HSA) and glycated (GHSA) human serum albumin were studied; when the formation of aggregates was induced by the simultaneous heating and addition of dithiotheritol. For the investigations, the biophysical methods of UV-vis spectrophotometry, circular dichroism spectroscopy, transmission electron microscopy and tensiometry were employed.&lt;br /&gt;
Results: The effect of inhibitory mechanism of these inhibitors on the aggregation of HSA and GHSA was expressed and compared together.&lt;br /&gt;
Conclusion: The results showed that the nucleus formation step of the aggregation process of HSA and GHSA was different in the presence of alginate (compared to &amp;beta;-cyclodextrin and trehalose). The inhibition efficiencies of the carbohydrates on the aggregate formation of HSA and GHSA were different, arising from the differences in the hydrophobicities of HSA and GHSA, and also, the differences between HSA- and GHSA-carbohydrate interactions.&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>126</FPAGE>
            <TPAGE>132</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Ali Akbar</Name>
<MidName></MidName>
<Family>Moosavi-Movahedi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Institute of Biochemistry and Biophysics, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Institute of Biochemistry and Biophysics, University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Naghmeh</Name>
<MidName></MidName>
<Family>Sattarahmady</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Medical Physics, Faculty of Medicine, Shiraz University of Medical SciencesNanobiology and Nanomedicine Research Center, Shiraz University of Medical SciencesPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Medical Physics, Faculty of Medicine, Shiraz University of Medical SciencesNanobiology and Nanomedicine Research Center, Shiraz University of Medical SciencesPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>IranIranIran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Esmaeil</Name>
<MidName></MidName>
<Family>Sharifi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Institute of Biochemistry and Biophysics, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Institute of Biochemistry and Biophysics, University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Hossein</Name>
<MidName></MidName>
<Family>Heli</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Nanobiology and Nanomedicine Research Center, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Nanobiology and Nanomedicine Research Center, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Albumin</KeyText></KEYWORD><KEYWORD><KeyText>Alginate</KeyText></KEYWORD><KEYWORD><KeyText>Protein aggregation</KeyText></KEYWORD><KEYWORD><KeyText>Trehalose</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>245.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Bagger HL, &#216;gendal LH, Westh P. Solute effects on the irreversible aggregation of serum albumin. Biophys Chem 2007;130(1-2):17-25.##Baynes BM, Wang DI, Trout BL. Role of arginine in the stabilization of proteins against aggregation. Biochemistry 2005;44(12):4919-4925.##Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 2005;99(4):303-310.##Brahma A, Mandal C, Bhattacharyya D. Characterization of a dimeric unfolding intermediate of bovine serum albumin under mildly acidic condition. Biochim Biophys Acta 2005;1751(2):159-169.##Lumry R, Eyring H. Conformation changes of proteins. J Phys Chem 1954;58(2):110-120.##Rezaei-Ghaleh N, Ebrahim-Habibi A, Moosavi-Movahedi AA, Nemat-Gorgani M. Role of electrostatic interactions in 2,2,2-trifluoroethanol-induced structural changes and aggregation of alpha-chymotrypsin. Arch Biochem Biophys 2007;457(2):160-169.##Fink AL. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 1998;3(1):R9-23.##Mierzeiewska D, Mitrowska P, Rudnicka B, Kubicka E, Kostyra H. Effect of non-enzymatic glycosylation of pea albumins on their immunoreactive properties. Food Chem 2008;111(1):127-131.##Lee MJ, Fennema OR. Ability of cyclodextrins to inhibit aggregation of beta-casein. J Agric Food Chem 1991;39(1):17-21.##Richards AB, Krakowka S, Dexter LB, Schmid H, Wolterbeek AP, Waalkens-Berendsen DH, et al. Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol 2002;40(7):871-898.##Wyatt GR, Kale GF. The chemistry of insect hemolymph. II. Trehalose and other carbohydrates. J Gen Physiol 1957;40(6):833-847.##Stephen AM, Phillips GO, Williams PA. Food Polysaccharides and Their Applications. New York, USA: CRC Press; 2006. 625p.##Hurst R, Bao Y, Ridley S, Williamson G. Phospholipid hydroperoxide cysteine peroxidase activity of human serum albumin. Biochem J 1999;338( Pt 3):723-728.##Kouoh F, Gressier B, Luyckx M, Brunet C, Dine T, Cazin M, et al. Antioxidant properties of albumin: effect on oxidative metabolism of human neutrophil granulocytes. Farmaco 1999;54(10):695-699.##Stirpe A, Pantusa M, Rizzuti B, Sportelli L, Bartucci R, Guzzi R. Early stage aggregation of human serum albumin in the presence of metal ions. Int J Biol Macromol 2011;49(3):337-342.##Rondeau P, Navarra G, Cacciabaudo F, Leone M, Bourdon E, Militello V. Thermal aggregation of glycated bovine serum albumin. Biochim Biophys Acta 2010;1804(4):789-798.##Barreca D, Lagan&#224; G, Ficarra S, Tellone E, Leuzzi U, Magaz&#249; S, et al. Anti-aggregation properties of trehalose on heat-induced secondary structure and conformation changes of bovine serum albumin. Biophys Chem 2010;147(3):146-152.##Sharma A, Pasha JM, Deep S. Effect of the sugar and polyol additives on the aggregation kinetics of BSA in the presence of N-cetyl-N,N,N-trimethyl ammonium bromide. J Colloid Interface Sci 2010;350(1):240-248.##Bhattacharya M, Jain N, Mukhopadhyay S. Insights into the mechanism of aggregation and fibril formation from bovine serum albumin. J Phys Chem B 2011;115(14):4195-4205.##Morgan PE, Treweek TM, Lindner RA, Price WE, Carver JA. Casein proteins as molecular chaperones. J Agric Food Chem 2005;53(7):2670-2683.##Baynes JW, Thorpe SR, Murtiashaw MH. Nonenzymatic glucosylation of lysine residues in albumin. Methods Enzymol 1984;106:88-98.##Bouma B, Kroon-Batenburg LM, Wu YP, Br&#252;njes B, Posthuma G, Kranenburg O, et al. Glycation induces formation of amyloid cross-beta structure in albumin. J Biol Chem 2003;278(43):41810-41819.##Holm NK, Jespersen SK, Thomassen LV, Wolff TY, Sehgal P, Thomsen LA, et al. Aggregation and fibrillation of bovine serum albumin. Biochim Biophys Acta 2007;1774(9):1128-1138.##Jain NK, Roy I. Role of trehalose in moisture-induced aggregation of bovine serum albumin. Eur J Pharm Biopharm 2008;69(3):824-834.##Kaushik JK, Bhat R. Why is trehalose an exceptional protein stabilizer? An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose. J Biol Chem 2003;278(29):26458-26465.##Michalke A, Janshoff A, Steinem C, Henke C, Sieber M, Galla HJ. Quantification of the interaction between charged guest molecules and chemisorbed monothiolated β-cyclodextrins. Anal Chem 1999;71(13):2528-2533.##Yang J, Goto M, Ise H, Cho CS, Akaike T. Galactosylated alginate as a scaffold for hepatocytes entrapment. Biomaterials 2002;23(2):471-479.##Sattarahmady N, Khodagholi F, Moosavi-Movahedi AA, Heli H, Hakimelahi GH. Alginate as an antiglycating agent for human serum albumin. Int J Biol Macromol 2007;41(2):180-184.##Zhao Y, Li F, Carvajal MT, Harris MT. Interactions between bovine serum albumin and alginate: an evaluation of alginate as protein carrier. J Colloid Interface Sci 2009;332(2):345-353.##Kuo HH, Chan C, Burrows LL, Deber CM. Hydrophobic interactions in complexes of antimicrobial peptides with bacterial polysaccharides. Chem Biol Drug Des 2007;69(6):405-412.##Imeson AP, Ledward DA, Mitchell JR. On the nature of interaction between some anionic polysaccharides and proteins. J Sci Food Agric 1977;28(8):661-668.##Stainsby G. Proteinaceous gelling system and their complexes with polysaccharides. Food Chem 1980;6(1):3-14.##Kaushik JK, Bhat R. Thermal stability of proteins in aqueous polyol solutions: Role of the surface tension of water in the stabilizing effect of polyols. J Phys Chem B 1998;102(36):7058-7066.##Peyrin E, Guillaume YC, Morin N, Guinchard C. Sucrose dependence of solute retention on human serum albumin stationary phase: hydrophobic effect and surface tension considerations. Anal Chem 1998;70(14):2812-2818.##Makievski AV, Fainerman VB, Bree M, Wustneck R, Kragel J, Miller R. Adsorption of proteins at liquid/air interface. J Phys Chem B 1998;102(2):417-425.##Messina P, Prieto G, Dodero V, Cabrerizo-V&#237;lchez MA, Maldonado-Valderrama J, Ruso JM, et al. Surface characterization of human serum albumin and sodium perfluorooctanoate mixed solutions by pendant drop tensiometry and circular dichroism. Biopolymers 2006;82(3):261-271.##Hirano A, Hamada H, Okubo T, Noguchi T, Higashibata H, Shiraki K. Correlation between thermal aggregation and stability of lysozyme with salts described by molar surface tension increment: an exceptional propensity of ammonium salts as aggregation suppressor. Protein J 2007;26(6):423-433.##Kim JR, Gibson TJ, Murphy RM. Targeted control of kinetics of beta-amyloid self-association by surface tension-modifying peptides. J Biol Chem 2003;278(42):40730-40735.##Arakawa T, Kita Y. Stabilizing effects of caprylate and acetyltryptophanate on heat-induced aggregation of bovine serum albumin. Biochim Biophys Acta 2000;1479(1-2):32-36.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Effect of Removal of Spermatogonial Stem Cells (SSCs) from In Vitro Culture on Gene Expression of Niche Factors in Bovine</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Niche cells, regulating Spermatogonial Stem Cells (SSCs) fate are believed to have a reciprocal communication with SSCs. The present study was conducted to evaluate the effect of SSC elimination on the gene expression of Glial cell line-Derived Neurotrophic Factor (GDNF), Fibroblast Growth Factor 2 (FGF2) and Kit Ligand (KITLG), which are the main growth factors regulating SSCs development and secreted by niche cells, primarily Sertoli cells.&lt;br /&gt;
Methods: Following isolation, bovine testicular cells were cultured for 12 days on extracellular matrix-coated plates. In the germ cell-removed group, the SSCs were removed from the&lt;em&gt; in vitro&lt;/em&gt; culture using differential plating; however, in the control group, no intervention in the culture was performed. Colony formation of SSCs was evaluated using an inverted microscope. The gene expression of growth factors and spermatogonia markers were assessed using quantitative real time PCR.&lt;br /&gt;
Results: SSCs colonies were developed in the control group but they were rarely observed in the germ cell-removed group; moreover, the expression of spermatogonia markers was detected in the control group while it was not observed in the germ cell-removed group, substantiating the success of SSCs removal. The expression of Gdnf and Fgf2 was greater in the germ cell-removed than control group (p&amp;lt;0.05), whereas the expression of Kitlg was lower in the germ cell-removed than control group (p&amp;lt;0.05).&lt;br /&gt;
Conclusion: In conclusion, the results revealed that niche cells respond to SSCs removal by upregulation of GDNF and FGF2, and downregulation of KITLG in order to stimulate self-renewal and arrest differentiation.&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>133</FPAGE>
            <TPAGE>138</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Vahid</Name>
<MidName></MidName>
<Family>Akbarinejad</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Theriogenology, Faculty of Veterinary Medicine, University of TehranTheriogenology Association, Faculty of Veterinary Medicine, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Department of Theriogenology, Faculty of Veterinary Medicine, University of TehranTheriogenology Association, Faculty of Veterinary Medicine, University of Tehran</University>
</Universities>
<Countries>
<Country>IranIran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Parviz</Name>
<MidName></MidName>
<Family>Tajik</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Theriogenology Association, Faculty of Veterinary Medicine, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Theriogenology Association, Faculty of Veterinary Medicine, University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mansooreh</Name>
<MidName></MidName>
<Family>Movahedian</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University</Organization>
</Organizations>
<Universities>
<University>Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Reza</Name>
<MidName></MidName>
<Family>Youssefi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Theriogenology, Faculty of Veterinary Medicine, University of TehranTheriogenology Association, Faculty of Veterinary Medicine, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Department of Theriogenology, Faculty of Veterinary Medicine, University of TehranTheriogenology Association, Faculty of Veterinary Medicine, University of Tehran</University>
</Universities>
<Countries>
<Country>IranIran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Bovine</KeyText></KEYWORD><KEYWORD><KeyText>Gene expression</KeyText></KEYWORD><KEYWORD><KeyText>Stem cells</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>246.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Oatley JM, Brinster RL. Regulation of spermatogonial stem cell self-renewal in mammals. Annu Rev Cell Dev Biol 2008;24:263-286.##Meng X, Lindahl M, Hyv&#246;nen ME, Parvinen M, de Rooij DG, Hess MW, et al. Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 2000;287(5457):1489-1493.##Ishii K, Kanatsu-Shinohara M, Toyokuni S, Shinohara T. FGF2 mediates mouse spermatogonial stem cell self-renewal via upregulation of Etv5 and Bcl6b through MAP2K1 activation. Development 2012;139(10):1734-1743.##Sato T, Yokonishi T, Komeya M, Katagiri K, Kubota Y, Matoba S, et al. Testis tissue explantation cures spermatogenic failure in c-Kit ligand mutant mice. Proc Natl Acad Sci USA 2012;109(42):16934-16938.##Hofmann MC, Braydich-Stolle L, Dym M. Isolation of male germ-line stem cells; influence of GDNF. Dev Biol 2005;279(1):114-124.##Johnston DS, Olivas E, DiCandeloro P, Wright WW. Stage-specific changes in GDNF expression by rat Sertoli cells: a possible regulator of the replication and differentiation of stem spermatogonia. Biol Reprod 2011;85(4):763-769.##Kubota H, Avarbock MR, Brinster RL. Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. Proc Natl Acad Sci USA 2004;101(47):16489-16494.##Aponte PM, Soda T, van de Kant HJ, de Rooij DG. Basic features of bovine spermatogonial culture and effects of glial cell line-derived neurotrophic factor. Theriogenology 2006;65(9):1828-1847.##Oatley JM, de Avila DM, Reeves JJ, McLean DJ. Testis tissue explant culture supports survival and proliferation of bovine spermatogonial stem cells. Biol Reprod 2004;70(3):625-631.##Zhang L, Tang J, Haines CJ, Feng HL, Lai L, Teng X, et al. c-kit and its related genes in spermatogonial differentiation. Spermatogenesis 2011;1(3):186-194.##Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009;326(5957):1216-1219.##Watt FM, Huck WT. Role of the extracellular matrix in regulating stem cell fate. Nat Rev Mol Cell Biol 2013;14(8):467-473.##Abbott A. Cell culture: biology&#39;s new dimension. Nature 2003;424(6951):870-872.##Rosso F, Giordano A, Barbarisi M, Barbarisi A. From cell-ECM interactions to tissue engineering. J Cell Physiol 2004;199(2):174-180.##Zhang S. Beyond the petri dish. Nat Biotechnol 2004;22(2):151-152.##Akbarinejad V, Tajik P, Movahedin M, Youssefi R, Shafiei S, Mazaheri Z. Effect of extracellular matrix on bovine spermatogonial stem cells and gene expression of niche factors regulating their development in vitro. Anim Reprod Sci 2015;157:95-102.##Lane SW, Williams DA, Watt FM. Modulating the stem cell niche for tissue regeneration. Nat Biotechnol 2014;32(8):795-803.##Nakagawa T, Sharma M, Nabeshima Y, Braun RE, Yoshida S. Functional hierarchy and reversibility within the murine spermatogenic stem cell compartment. Science 2010;328(5974):62-67.##Tadokoro Y, Yomogida K, Ohta H, Tohda A, Nishimune Y. Homeostatic regulation of germinal stem cell proliferation by the GDNF/FSH pathway. Mech Dev 2002;113(1):29-39.##Caires KC, de Avila J, McLean DJ. Endocrine regulation of spermatogonial stem cells in the seminiferous epithelium of adult mice. Biores Open Access 2012;1(5):222-230.##Zohni K, Zhang X, Tan SL, Chan P, Nagano MC. The efficiency of male fertility restoration is dependent on the recovery kinetics of spermatogonial stem cells after cytotoxic treatment with busulfan in mice. Hum Reprod 2012;27(1):44-53.##Choi YJ, Ok DW, Kwon DN, Chung JI, Kim HC, Yeo SM, et al. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL- and p53-independent manner. FEBS Lett 2004;575(1-3):41-51.##Howell SJ, Shalet SM. Testicular function following chemotherapy. Hum Reprod Update 2001;7(4):363-369.##Oatley JM. Spermatogonial stem cell biology in the bull: development of isolation, culture, and transplantation methodologies and their potential impacts on cattle production. Soc Reprod Fertil Suppl 2010;67:133-143.##Shafiei Sh, Tajik P, Ghasemzadeh-nava H, Movahedin M, Talebkhan Garoussi M, Qasemi-Panahi B, et al. Isolation of bovine spermatogonial cells and co-culture with prepubertal sertoli cells in the presence of colony stimulating factor-1. Iran J Vet Med 2013;7(2):83-90.##He Z, Kokkinaki M, Jiang J, Dobrinski I, Dym M. Isolation, characterization, and culture of human spermatogonia. Biol Reprod 2010;82(2):363-372.##Reding SC, Stepnoski AL, Cloninger EW, Oatley JM. THY1 is a conserved marker of undifferentiated spermatogonia in the pre-pubertal bull testis. Reproduction 2010;139(5):893-903.##Izadyar F, Den Ouden K, Creemers LB, Posthuma G, Parvinen M, De Rooij DG. Proliferation and differentiation of bovine type A spermatogonia during long-term culture. Biol Reprod 2003;68(1):272-281.##Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402-408.##Statistical Analysis Systems Institute. User’s Guide Version 9.2: Statistics. SAS Institute, Cary NC, USA; 2008.##Yomogida K, Yagura Y, Tadokoro Y, Nishimune Y. Dramatic expansion of germinal stem cells by ectopically expressed human glial cell line-derived neurotrophic factor in mouse Sertoli cells. Biol Reprod 2003;69(4):1303-1307.##Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990;63(1):213-224.##Brannan CI, Lyman SD, Williams DE, Eisenman J, Anderson DM, Cosman D, et al. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci USA 1991;88(11):4671-4674.##Kanatsu-Shinohara M, Ogura A, Ikegawa M, Inoue K, Ogonuki N, Tashiro K, et al. Adenovirus-mediated gene delivery and in vitro microinsemination produce offspring from infertile male mice. Proc Natl Acad Sci USA 2002;99(3):1383-1388.##Ikawa M, Tergaonkar V, Ogura A, Ogonuki N, Inoue K, Verma IM. Restoration of spermatogenesis by lentiviral gene transfer: offspring from infertile mice. Proc Natl Acad Sci USA 2002;99(11):7524-7529.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>The Effect of Media Supplementation with Angiotensin on Developmental Competence of Ovine Embryos Derived from Vitrified-warmed Oocytes</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: This study was aimed to assess the effects of angiotensin II (Ang II) supplementation to the In Vitro Maturation (IVM) and In Vitro Culture (IVC) media of vitrified-warmed ovine oocytes on their developmental competence and expression of Na&lt;sup&gt;+&lt;/sup&gt;/K&lt;sup&gt;+&lt;/sup&gt;/ATPase in resulting embryos.&lt;br /&gt;
Methods: The slaughterhouse-derived immature oocytes (n=1069) were randomly distributed into four experimental groups: groups I and II) IVM/IVF and IVC of fresh and vitrified oocytes without angiotensin supplementation (Control-Fresh and Control-Vit groups, respectively); group III) IVM of vitrified oocytes in the presence of Ang II followed by IVF/IVC (Vit-IVM group); and group IV) IVM/IVF of vitrified oocytes followed by IVC wherein the embryos were exposed to Ang II on day 4 of IVC (Vit-D4 group). The embryos were immunostained with primary antibodies against Na&lt;sup&gt;+&lt;/sup&gt;/K&lt;sup&gt;+&lt;/sup&gt;/ATPase &amp;alpha;&lt;sub&gt;1&lt;/sub&gt; and &amp;beta;&lt;sub&gt;1&lt;/sub&gt; subunits.&lt;br /&gt;
Results: In Vit-IVM and Vit-D4 groups, the rates of expanded and total blastocysts on day 7 as well as the proportion of blastocysts on day 8 were increased. The expression of Na&lt;sup&gt;+&lt;/sup&gt;/K&lt;sup&gt;+&lt;/sup&gt;/ATPase &amp;alpha;1 and &amp;beta;&lt;sub&gt;1&lt;/sub&gt; subunits were positively influenced by the addition of Ang II on day 4 (Vit-D4 group).&lt;br /&gt;
Conclusion: The addition of Ang II to the IVM and IVC media could improve blastocysts formation in vitrified sheep oocytes. This improvement might be related to the greater expression of Na&lt;sup&gt;+&lt;/sup&gt;/K&lt;sup&gt;+&lt;/sup&gt;/ATPase &amp;alpha;&lt;sub&gt;1&lt;/sub&gt; and &amp;beta;&lt;sub&gt;1&lt;/sub&gt; subunits when Ang II was added during IVC.&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>139</FPAGE>
            <TPAGE>144</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mohammad Mehdi</Name>
<MidName></MidName>
<Family>Naderi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sara</Name>
<MidName></MidName>
<Family>Borjian Boroujeni</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ali</Name>
<MidName></MidName>
<Family>Sarvari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Banafsheh</Name>
<MidName></MidName>
<Family>Heidari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad Mehdi</Name>
<MidName></MidName>
<Family>Akhondi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Amir-Hassan</Name>
<MidName></MidName>
<Family>Zarnani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Immunology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Immunology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Abolfazl</Name>
<MidName></MidName>
<Family>Shirazi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECRResearch Institute of Animal Embryo Technology, Shahrekord University</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECRResearch Institute of Animal Embryo Technology, Shahrekord University</University>
</Universities>
<Countries>
<Country>IranIran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Angiotensin II</KeyText></KEYWORD><KEYWORD><KeyText>Na+/K+/ATPase</KeyText></KEYWORD><KEYWORD><KeyText>Oocyte</KeyText></KEYWORD><KEYWORD><KeyText>Ovine </KeyText></KEYWORD><KEYWORD><KeyText>Vitrification</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>247.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Luciano AM, Chigioni S, Lodde V, Franciosi F, Luvoni GC, Modina SC. Effect of different cryopreservation protocols on cytoskeleton and gap junction mediated communication integrity in feline germinal vesicle stage oocytes. Cryobiology 2009;59(1):90-95.##Mullen SF, Fahy GM. A chronologic review of mature oocyte vitrification research in cattle, pigs, and sheep. Theriogenology 2012;78(8):1709-1719.##Naderi MM, Borjian Boroujeni S, Sarvari A, Heidari B, Akhondi MM, Zarnani AH, et al. The effect of angiotensin on the quality of in vitro produced (IVP) sheep embryos and expression of Na(+)/K(+)/ATPase. Avicenna J Med Biotechnol 2016;8(1):9-15.##Kojouri GA, Shirazi  A. Serum concentrations of Cu, Zn, Fe, Mo and Co in newborn lambs following systemic administration of Vitamin E and selenium to the pregnant ewes. Small Rumin Res 2007;70(2-3):136-139.##Shirazi A, Sadeghi N. The effect of ovine oocyte diameter on nuclear maturation. Small Rumin Res 2007;69(1-3):103-107.##Stefanello JR, Barreta MH, Porciuncula PM, Arruda JN, Oliveira JF, Oliveira MA, et al. Effect of angiotensin II with follicle cells and insulin-like growth factor-I or insulin on bovine oocyte maturation and embryo development. Theriogenology 2006;66(9):2068-2076.##Sirard MA, Lambert RD. Birth of calves after in vitro fertilisation using laparoscopy and rabbit oviduct incubation of zygotes. Vet Rec 1986;119(8):167-169.##Sarvari A, Naderi MM, Sadeghi MR, Akhondi MM. A technique for facile and precise transfer of mouse embryos. Avicenna J Med Biotechnol 2013;5(1):62-65.##Schauser KH, Nielsen AH, Winther H, Dantzer V, Poulsen K. Dominance of type 1 angiotensin II receptor in the nonpregnant and pregnant bovine uterus. J Reprod Fertil 1999;116(2):403-413.##Wijayagunawardane MP, Kodithuwakku SP, DE Silva NT, Miyamoto A. Angiotensin II secretion by the bovine oviduct is stimulated by luteinizing hormone and ovarian steroids. J Reprod Dev 2009;55(5):570-575.##Pijacka W, Hunter MG, Broughton Pipkin F, Luck MR. Expression of renin-angiotensin system components in the early bovine embryo. Endocr Connect 2012;1(1):22-30.##Honorato-Sampaio K, Pereira VM, Santos RA, Reis AM. Evidence that angiotensin-(1-7) is an intermediate of gonadotrophin-induced oocyte maturation in the rat preovulatory follicle. Exp Physiol 2012;97(5):642-650.##Giometti IC, Bertagnolli AC, Ornes RC, da Costa LF, Carambula SF, Reis AM, et al. Angiotensin II reverses the inhibitory action produced by theca cells on bovine oocyte nuclear maturation. Theriogenology 2005;63(4):1014-1025.##Muscella A, Aloisi F, Marsigliante S, Levi G. Angiotensin II modulates the activity of Na+,K+-ATPase in cultured rat astrocytes via the AT1 receptor and protein kinase C-delta activation. J Neurochem 2000;74(3):1325-1331.##Min LJ, Mogi M, Iwai M, Horiuchi M. Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing Res Rev 2009;8(2):113-121.##Succu S, Bebbere D, Bogliolo L, Ariu F, Fois S, Leoni GG, et al. Vitrification of in vitro matured ovine oocytes affects in vitro pre-implantation development and mRNA abundance. Mol Reprod Dev 2008;75(3):538-546.##Madan P, Rose K, Watson AJ. Na/K-ATPase beta1 subunit expression is required for blastocyst formation and normal assembly of trophectoderm tight junction-associated proteins. J Biol Chem 2007;282(16):12127-12134.##Shirazi A, Ardali MA, Ahmadi E, Nazari H, Mamuee M, Heidari B. The effect of macromolecule source and type of media during in vitro maturation of sheep oocytes on subsequent embryo development. J Reprod Infertil 2012;13(1):13-19.##Naderi MM, Sarvari A, Saviz A, Naji T,  Borjian Boroujeni S, Heidari B, et al. The effect of aldosterone on Na+/K+/ATPase expression and development of embryos derived from vitrified-warmed sheep oocytes. Small Rumin Res 2015;126:44-51.##Lim JM, Hansel W. Exogeneous substances affecting development of in vitro-derived bovine embryos before and after embryonic genome activation. Theriogenology 2000;53(5):1081-1091.##Houghton FD, Humpherson PG, Hawkhead JA, Hall CJ, Leese HJ. Na+, K+, ATPase activity in the human and bovine preimplantation embryo. Dev Biol 2003;263(2):360-366.##Gomez E, Caama&#241;o JN, Bermejo-Alvarez P, Diez C, Mu&#241;oz M, Martin D, et al. Gene expression in early expanded parthenogenetic and in vitro fertilized bovine blastocysts. J Reprod Dev 2009;55(6):607-614.##Violette MI, Madan P, Watson AJ. Na+/K+ -ATPase regulates tight junction formation and function during mouse preimplantation development. Dev Biol 2006;289(2):406-419.##Gomes CP, Le&#227;o-Ferreira LR, Caruso-Neves C, Lopes AG. Adenosine reverses the stimulatory effect of angiotensin II on the renal Na+-ATPase activity through the A2 receptor. Regul Pept 2005;129(1-3):9-15##Lara LS, De Carvalho T, Le&#227;o-Ferreira LR, Lopes AG, Caruso-Neves C. Modulation of the (Na(+)+K+)ATPase activity by Angiotensin-(1-7) in MDCK cells. Regul Pept 2005;129(1-3):221-226.##Isenovic ER, Jacobs DB, Kedees MH, Sha Q, Milivojevic N, Kawakami K, et al. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells. Endocrinology 2004;145(3):1151-1160.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Leptin Receptor Gene Polymorphism may Affect Subclinical Atherosclerosis in Patients with Acromegaly</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Acromegaly is associated with increased morbidity and mortality related to cardiovascular diseases. Leptin (LEP) and Leptin Receptor (LEPR) gene polymorphisms can increase cardiovascular risks. The aim of this study was to investigate association between the frequencies of LEP and LEPR gene polymorphisms and subclinical atherosclerosis in acromegalic patients.&lt;br /&gt;
Methods: Forty-four acromegalic patients and 30 controls were admitted to study. The polymorphisms were identified by using polymerase chain reaction from peripheral blood samples. The levels of systolic and diastolic blood pressure, BMI, fasting plasma glucose, fasting insulin, IGF-I, GH, IGFBP3, leptin, triglyceride, carotid Intima Media Thickness (cIMT) and HDL and LDL cholesterol concentrations were evaluated.&lt;br /&gt;
Results: There was statistically significant difference between the LEPR genotypes of acromegalic patients (GG 11.4%, GA 52.3%, and AA 36.4%) and controls (GG 33.3%, GA 50%, and AA 16.7%) although their LEP genotype distribution was similar. In addition, the prevalence of the LEPR gene G and A alleles was significantly different between patients and controls. No significant difference was found among the G(-2548)A leptin genotypes of groups in terms of the clinical parameters. cIMT significantly increased homozygote LEPR GG genotype group compared to AA subjects in patients. But the other parameters were not different between LEPR genotypes groups of patients and controls.&lt;br /&gt;
Conclusion: It can be said that the LEPR gene polymorphism may affect cIMT in patients. The reason is that LEPR GG genotype carriers may have more risk than other genotypes in the development of subclinical atherosclerosis in acromegaly.&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>145</FPAGE>
            <TPAGE>150</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Sebahat</Name>
<MidName></MidName>
<Family>Turgut</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, Faculty of Medicine, University of Pamukkale</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, Faculty of Medicine, University of Pamukkale</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Senay</Name>
<MidName></MidName>
<Family>Topsakal</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Pamukkale</Organization>
</Organizations>
<Universities>
<University>Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Pamukkale</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Melek</Name>
<MidName></MidName>
<Family>Tun&#231; Ata</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, Faculty of Medicine, University of Pamukkale</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, Faculty of Medicine, University of Pamukkale</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Duygu</Name>
<MidName></MidName>
<Family>Herek</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Radiology, Faculty of Medicine, University of Pamukkale</Organization>
</Organizations>
<Universities>
<University>Department of Radiology, Faculty of Medicine, University of Pamukkale</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fulya</Name>
<MidName></MidName>
<Family>Akın</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Pamukkale</Organization>
</Organizations>
<Universities>
<University>Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Pamukkale</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Şeyma</Name>
<MidName></MidName>
<Family>&#214;zkan</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, Faculty of Medicine, University of Pamukkale</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, Faculty of Medicine, University of Pamukkale</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>G&#252;nfer</Name>
<MidName></MidName>
<Family>Turgut</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, Faculty of Medicine, University of Pamukkale</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, Faculty of Medicine, University of Pamukkale</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Acromegaly</KeyText></KEYWORD><KEYWORD><KeyText>Leptin</KeyText></KEYWORD><KEYWORD><KeyText>Polymorphism</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>248.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25(1):102-152.##Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 2004;89(2):667-674.##Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395(6704):763-770.##Sun Q, Cornelis MC, Kraft P, Qi L, van Dam RM, Girman CJ, et al. Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels. Hum Mol Genet 2010;19(9):1846-1855.##Fr&#252;hbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006;393(Pt 1):7-20.##Constantin A, Costache G, Sima AV, Glavce CS, Vladica M, Popov DL. Leptin G-2548A and leptin receptor Q223R gene polymorphisms are not associated with obesity in Romanian subjects. Biochem Biophys Res Commun 2010;391(1):282-286.##Şahın S, R&#252;stemoğlu A, Tekcan A, Taşliyurt T, G&#252;ven H, Yığıt S. Investigation of associations between obesity and LEP G2548A and LEPR 668A/G polymorphisms in a Turkish population. Dis Markers 2013;35(6):673-677.##Becer E, Mehmet&#231;ik G, Bareke H, Serakıncı N. Association of leptin receptor gene Q223R polymorphism on lipid profiles in comparison study between obese and non-obese subjects. Gene 2013;529(1):16-20.##Mohammadzadeh G, Ghaffari MA, Bafandeh A, Hosseini SM. Effect of leptin receptor Q223R polymorphism on breast cancer risk. Iran J Basic Med Sci 2014;17(8):588-594.##Mukherjee D, Yadav JS. Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J 2002;144(5):753-759.##Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87(3 Suppl):II56-65.##Colao A, Marzullo P, Lombardi G. Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly. Eur J Endocrinol 2002;146(3):303-309.##Otsuki M, Kasayama S, Yamamoto H, Saito H, Sumitani S, Kouhara H, et al. Characterization of premature atherosclerosis of carotid arteries in acromegalic patients. Clin Endocrinol (Oxf) 2001;54(6):791-796.##Vitale G, Pivonello R, Lombardi G, Colao A. [Cardiovascular complications in acromegaly]. Minerva Endocrinol 2004;29(3):77-88. English, Italian.##Freda PU. Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 2003;13(4):171-184.##Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012;34(4):290-296.##Hochberg I, Tran QT, Barkan AL, Saltiel AR, Chandler WF, Bridges D. Gene expression signature in adipose tissue of acromegaly patients. PLoS One 2015;10(6):e0129359.##Gl&#228;ser S, Friedrich N, Ewert R, Sch&#228;per C, Nauck M, D&#246;rr M, et al. Association between serum insulin-like growth factor (IGF) I and IGF binding protein-3 and lung function. J Clin Endocrinol Metab 2009;94(7):2452-2458.##Seravalle G, Carzaniga C, Attanasio R, Grassi G, Lonati L, Facchini C, et al. Decreased adrenergic tone in acromegaly: evidence from direct recording of muscle sympathetic nerve activity. Clin Endocrinol (Oxf) 2012;77(2):262-267.##Olarescu NC, Ueland T, Lekva T, Dahl TB, Halvorsen B, Aukrust P, et al. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltrans ferase/visfatin in active acromegaly. J Clin Endocrinol Metab 2012;97(4):1355-1362.##Seravalle G, Carzaniga C, Sciortino G, Attanasio R, Fatti LM, Cozzi R, et al. Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease. Clin Exp Pharmacol Physiol 2013;40(5):333-337.##Roemmler J, Otto B, Arafat AM, Bidlingmaier M, Schopohl J. Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patients. Eur J Endocrinol 2010;163(5):727-734.##Gurbulak S, Yaylali GF, Yerlikaya E, Akin F, Topsakal S, Tanrverdi H, et al. Resistin and leptin levels in acromegaly: lack of correlation with echocardiographic findings. J Investig Med 2013;61(3):582-585.##Olarescu NC, Heck A, Godang K, Ueland T, Bollerslev J. The metabolic risk in newly diagnosed patients with acromegaly is related to fat distribution and circulating adipokines and improves after treatment. Neuroendocrinology 2015.##Ciresi A, Amato MC, Pizzolanti G, Giordano Galluzzo C. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. J Clin Endocrinol Metab 2012;97(8):2907-2915.##Le Stunff C, Le Bihan C, Schork NJ, Bougn&#232;res P. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 2000;49(12):2196-2200.##G&#246;rm&#252;ş U, Tımırcı Kahraman &#214;, Toptaş B, İsbır T, &#199;ıft&#231;ı &#199;, Berkkan HH, et al. Leptin and leptin receptor polymorphisms are related to body mass index in a Turkish population. Turk J Med Sci 2014;44(5):809-813.##Su PH, Yang SF, Yu JS, Chen SJ, Chen JY. A polymorphism in the leptin receptor gene at position 223 is associated with growth hormone replacement therapy responsiveness in idiopathic short stature and growth hormone deficiency patients. Eur J Med Genet 2012;55(12):682-687.##Gaukrodger N, Mayosi BM, Imrie H, Avery P, Baker M, Connell JM, et al. A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. J Med Genet 2005;42(6):474-478.##Stefan N, Vozarova B, Del Parigi A, Ossowski V, Thompson DB, Hanson RL, et al. The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int J Obes Relat Metab Disord 2002;26(12):1629-1632.##Furusawa T, Naka I, Yamauchi T, Natsuhara K, Kimura R, Nakazawa M, et al. The Q223R polymorphism in LEPR is associated with obesity in Pacific Islanders. Hum Genet 2010;127(3):287-294.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

    </ARTICLES>
  </JOURNAL>
</XML>
